IRON NASDAQ
Disc Medicine, Inc.
1W: -1.2%
1M: -0.2%
3M: +8.4%
YTD: -5.6%
1Y: +23.2%
3Y: +63.0%
5Y: +41.4%
$74.65
+0.04 (+0.05%)
Weekly Expected Move ±5.8%
$66
$70
$74
$78
$83
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.9B
52W Range40-99.5
Volume295,482
Avg Volume570,651
Beta2.07
Dividend—
Analyst Ratings
Company Info
CEOJohn D. Quisel
Employees155
SectorHealthcare
IndustryBiotechnology
IPO Date2020-08-12
Websitediscmedicine.com
321 Arsenal Street
Watertown, MA 02472
US
Watertown, MA 02472
US
617 674 9274
About Disc Medicine, Inc.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Latest News
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
Disc Medicine gets FDA onboard with approval path for rare disease therapy
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Quisel John D | S-Sale | 9,704 | $74.27 | 2026-07-13 |
| Quisel John D | S-Sale | 16,896 | $74.95 | 2026-07-13 |
| Quisel John D | S-Sale | 6,400 | $76.05 | 2026-07-13 |
| Yu Jonathan Yen-Wen | S-Sale | 100 | $82.50 | 2026-07-07 |
| Khara Rahul | S-Sale | 1,649 | $75.00 | 2026-06-29 |